Efficacy and Safety of Cabozantinib Combined Chemotherapy as First-Line Treatment for HER2-Negative Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Advances in Clinical Medicine 2026

View at publisher

Authors: 丹彤赵

DOI: 10.12677/acm.2026.163836

Cited by: 0

References: 14

Fields of Study & Subjects

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Intraperitoneal and Appendiceal Malignancies

References 14